Screener
Pulse Biosciences, Inc. PLSE Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
FAQ
- What is Pulse Biosciences, Inc.'s total liabilities?
- Pulse Biosciences, Inc. (PLSE) reported total liabilities of $16.06M in Q2 2026.
- How has Pulse Biosciences, Inc.'s total liabilities changed year-over-year?
- Pulse Biosciences, Inc.'s total liabilities increased by 1.9% year-over-year, from $15.76M to $16.06M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Pulse Biosciences, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude